Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study

1. Shah, M.A.
2. Yoshino, T.
3. Tebbutt, N.C.
4. Grothey, A.
5. Tabernero, J.
6. Xu, R.-H.
7. Cervantes, A.
8. Oh, S.C.
9. Yamaguchi, K.
10. Fakih, M.
11. Falcone, A.
12. Wu, C.
13. Chiu, V.K.
14. Tomasek, J.
15. Bendell, J.
16. Fontaine, M.
17. Hitron, M.
18. Xu, B.
19. Taieb, J.
20. Van Cutsem, E.